Genentech, Inc. Will Focus on Developing Drugs in the Neuroscience and Infectious Disease Categories as Well as Finding New Uses for Current Best-Sellers

WSJ -- Genentech Inc. will focus on developing drugs in the neuroscience and infectious disease categories as well as finding new uses for current best-sellers, said Susan Desmond-Hellmann, president of product development.